| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Apr―03 |
Integratively screening SARS-CoV-2 3CLpro inhibitors from Coptidis Rhizoma applying activity fingerprinting and molecular docking program |
Bihe Zhu, Xiaoyan Wang, Min Han, Han Qin, Jin Li, Shujing Chen, et al. (+2) Kunze Du, Yanxu Chang |
| 2 |
[GO] |
2026―Jan―19 |
High-sensitivity dual analysis of Baricitinib and remdesivir in serum and urine using HPLC-fluorescence and LC-MS approaches in COVID-19 therapy |
Hazim M. Ali, Lateefa A. Al-Khateeb, Mohammed M. Ghoneim, Maha M. Abdelrahman, Ismail M. Ahmed, Mohammed Gamal |
| 3 |
[GO] |
2025―Jul―07 |
Development and computational analysis of new alkaloid derivatives as potential inhibitors of the SARS-CoV-2 Mpro |
Gulim Mukusheva, Manshuk Nurmaganbetova, Zharkin Zhumagaliyeva, Madina Aliyeva, Nurizat Toigambekova |
| 4 |
[GO] |
2025―Jun―23 |
Decoding serum N-Glycome signatures across COVID-19 symptomatic stages |
Mehmet Emrah Yaman, Haci Mehmet Kayili, İzzet Avci, Alperen Aksakal, Omer Faruk Kocak, Mehmet Atakay, Bekir Salih |
| 5 |
[GO] |
2024―Sep―27 |
An unconventional strategy for purifying recombinant SARS-CoV-2 spike protein |
Mrunal Ingawale, Mohammad Riaz, Yves Durocher, Raja Ghosh |
| 6 |
[GO] |
2024―Jul―16 |
Development of a high-performance liquid chromatography using rhodamine B hydrazide as the derivatization reagent for determination of β propiolactone residues in inactivated COVID-19 vaccines |
Seyedeh Zohreh Mirjalili, Fatemeh Chavoshi, Mohsen Amini, Farzad Kobarfard, Mehrnoosh Shirangi |
| 7 |
[GO] |
2022―Dec―20 |
A fast, efficient, and scalable method for purifying recombinant SARS-CoV-2 spike protein |
Nikhila Butani, Yating Xu, Si Pan, Yves Durocher, Raja Ghosh |
| 8 |
[GO] |
2022―Oct―17 |
Simultaneous quantification of nirmatrelvir and ritonavir by LC-MS/MS in patients treated for COVID-19 |
Jens Martens-Lobenhoffer, Corinna R. Böger, Jan Kielstein, Stefanie M. Bode-Böger |
| 9 |
[GO] |
2021―Dec―29 |
Menthol-assisted homogenous liquid-liquid microextraction for HPLC/UV determination of favipiravir as an antiviral for COVID-19 in human plasma |
Inas A. Abdallah, Sherin F. Hammad, Alaa Bedair, Fotouh R. Mansour |
| 10 |
[GO] |
2021―Aug―05 |
Simultaneous quantification of spike and nucleocapsid protein in inactivate COVID-19 vaccine bulk by liquid chromatography-tandem mass spectrometry |
Zhen Long, Chen Wei, Dong Xuefang, Xiuling Li, Hao Yang, Haiqing Deng, et al. (+4) Xiao Ma, Shanshan Yin, Yingzi Qi, Tao Bo |
